000 | 01437 a2200433 4500 | ||
---|---|---|---|
005 | 20250516205511.0 | ||
264 | 0 | _c20141118 | |
008 | 201411s 0 0 eng d | ||
022 | _a1097-0215 | ||
024 | 7 |
_a10.1002/ijc.28887 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCatsburg, Chelsea | |
245 | 0 | 0 |
_aAdherence to cancer prevention guidelines and risk of breast cancer. _h[electronic resource] |
260 |
_bInternational journal of cancer _cNov 2014 |
||
300 |
_a2444-52 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLymphatic Metastasis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aSurvival Rate |
700 | 1 | _aMiller, Anthony B | |
700 | 1 | _aRohan, Thomas E | |
773 | 0 |
_tInternational journal of cancer _gvol. 135 _gno. 10 _gp. 2444-52 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/ijc.28887 _zAvailable from publisher's website |
999 |
_c23728429 _d23728429 |